8 research outputs found

    Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate

    No full text
    AIM: To evaluate and characterize the patterns of disease progression of metastatic or unresectable gastrointestinal stromal tumor (GIST) treated with imatinib mesylate, and to determine the prognostic significance associated with disease progression
    corecore